|
Cannabis policy: status and recent developments (topic overview) |
2016 |
Topic overviews |
|
|
Drug-related infectious diseases in Europe: update from the EMCDDA expert network |
2016 |
Rapid communication |
English |
|
New psychoactive substances in Europe: legislation and prosecution — current challenges and solutions |
2016 |
Joint publications |
English |
|
Drugnet Europe 96 |
2016 |
Drugnet Europe |
English |
|
How can contingency management support treatment for substance use disorders? A systematic review |
2016 |
EMCDDA Papers |
English |
|
ESPAD Report 2015 — Results from the European School Survey Project on Alcohol and Other Drugs |
2016 |
Joint publications |
English |
|
ESPAD Report 2015: promotional brochure |
2016 |
Brochures |
English |
|
EU Drug Markets Report: promotional brochure |
2016 |
Brochures |
English |
|
Hospital emergency presentations and acute drug toxicity in Europe — update from the Euro-DEN Plus research group and the EMCDDA |
2016 |
Rapid communication |
English |
|
Hepatitis C among drug users in Europe: epidemiology, treatment and prevention |
2016 |
Insights |
English |
|
Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) |
2016 |
Risk assessments |
English |
|
EMCDDA–Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA |
2016 |
Implementation reports |
English |
|
EMCDDA–Europol Joint Report on MDMB-CHMICA |
2016 |
Joint Reports |
English |
|
Annual accounts 2015 |
2016 |
Annual account |
English |
|
Drugnet Europe 95 |
2016 |
Drugnet Europe |
English |
|
Health responses to new psychoactive substances (Perspectives on Drugs) |
2016 |
Perspectives on Drugs (PODs) |
English |
|
Health responses to new psychoactive substances |
2016 |
Rapid communication |
English |
|
General Report of Activities 2015 — Key achievements and governance: a year in review |
2016 |
General report of activities |
English |
|
EMCDDA–Europol Joint Report on acetylfentanyl |
2016 |
Joint Reports |
English |
|
Comorbidity of substance use and mental health disorders in Europe (Perspectives on drugs) |
2016 |
Perspectives on Drugs (PODs) |
English |
